Skip to content

Author

Kang-Yin Chen

We have 4 of 68 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Aug 2026

Comorbidity phenotypes, prognostic implications and ABC pathway effectiveness in early-onset atrial fibrillation patients: A latent class analysis from the Tianjin Atrial Fibrillation Project.

Three heterogeneous comorbidity-based phenotype clusters were identified in early-onset AF patients, associated with different treatment and prognosis, and full ABC pathway adherence improved prognosis in younger AF patients, regardless of their comorbidity phenotypes.

Xu Tian, Zijie Ding, Jin-Hua Zhao et al. · 0 citations
Open access Aug 2026

SerpinA3 is an Endogenous TGF‐β Receptor Antagonist that Attenuates Cardiac Fibroblast Activation and Fibrotic Remodeling

SerpinA3 functions as an endogenous inhibitor of TGF‐β signaling that restrains cardiac fibroblast activation and fibrotic remodeling and is identified as a promising therapeutic target for HF associated with pathological fibrosis.

Hui Wang, Jie Cui, Chun-Lu Huang et al. · 0 citations
Open access Aug 2026

Beta-Blocker Use After Acute Myocardial Infarction

Among patients with AMI complicated by HF, in-hospital BB use was associated with lower 1-year adverse outcomes risk in HFrEF/HFmrEF, but not in HFpEF.

Tian-Shu Gu, Su-Tao Hu, Yu-Kun Zhang et al. · 0 citations
Open access Aug 2026

LDL-C–stratified residual lipoprotein(a) and inflammatory risk after acute myocardial infarction among patients with prior statin use

In patients with AMI despite documented prior statin exposure, the prognostic associations of residual inflammatory and Lp(a) risk appeared to differ across admission LDL-C strata, supporting the potential value of LDL-C–stratified residual risk assessment.

Tian-Shu Gu, Yu-Xin Zhang, Li-Han Zhu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.